Real-time SEC alerts Start Free →
Profitelligence
Tilray Brands Inc.
TLRY HIGH Impact

Tilray Brands Inc.

Tilray Brands Announces 1-for-10 Reverse Stock Split

| 8-K |Healthcare

Summary

Tilray Brands, Inc. announced a 1-for-10 reverse stock split of its common stock, effective as of December 1, 2025. This action aligns the company's shares with industry peers, enhances appeal to institutional investors, and reduces annual meeting costs by up to $1 million. Stockholders will receive cash for any fractional shares, and trading will commence on a split-adjusted basis on December 2, 2025, under the symbol TLRY with a new CUSIP number of 88688T209.

Profitelligence Profitelligence Alerts

Get alerts for TLRY

Be first to know when Tilray Brands Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Material Modification of Rights of Security Holders Shareholder Rights Plan (Poison Pill) Corporate Update Regulatory Investigation Exhibits Furnished

Advertisement

About Tilray Brands Inc.

Tilray Brands Inc. is a pioneering player in the emerging global cannabis industry. A diversified company, it engages in the research, cultivation, production, and distribution of cannabis and hemp-based products. Tilray's primary function is to develop, produce, and distribute a wide range of medicinal and recreational cannabis products, including dried flower, extracts, and edibles. The company also produces hemp foods and alcoholic beverages. Founded in 2013, Tilray has rapidly gained a significant foothold, serving both medical patients and recreational consumers in multiple countries, including Canada, the United States, and parts of Europe. Tilray Brands Inc. operates within an industry that intersects with pharmaceuticals, consumer goods, and agriculture, heavily impacting sectors such as healthcare, wellness, and food and beverages. Through strategic acquisitions and partnerships, Tilray broadens its product offerings and global market presence. Its emphasis on research and innovation propels its market significance, especially as the demand for alternative wellness products grows. With the cannabis sector continuing to evolve, Tilray is poised as a key contributor to shaping market dynamics, establishing itself as a reputable brand committed to high-quality cannabis and cannabinoid-based products.

Exchange: NASDAQ Industry: Drug Manufacturers - Specialty & Generic Company Website →

Official SEC Documents

TLRY
TLRY Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement